Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T88015 | Target Info | |||
Target Name | COVID-19 3C-like protease (3CLpro) | ||||
Synonyms | COVID-19 3CL-PRO; COVID-19 3CLp; COVID-19 nsp5 | ||||
Gene Name | COVID-19 rep | ||||
Biochemical Class | Coronaviruses polyprotein 1ab family | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | N-Ethylsuccinimide | Ligand Info | |||
Canonical SMILES | CCN1C(=O)CCC1=O | ||||
InChI | 1S/C6H9NO2/c1-2-7-5(8)3-4-6(7)9/h2-4H2,1H3 | ||||
InChIKey | GHAZCVNUKKZTLG-UHFFFAOYSA-N | ||||
PubChem Compound ID | 16842 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 6XB1 Room temperature X-ray crystallography reveals catalytic cysteine in the SARS-CoV-2 3CL Mpro is highly reactive: Insights for enzyme mechanism and drug design | ||||||
Method | X-ray diffraction | Resolution | 1.80 Å | Mutation | No | [1] |
PDB Sequence |
SGFRKMAFPS
10 GKVEGCMVQV20 TCGTTTLNGL30 WLDDVVYCPR40 HVICTSEDML50 NPNYEDLLIR 60 KSNHNFLVQA70 GNVQLRVIGH80 SMQNCVLKLK90 VDTANPKTPK100 YKFVRIQPGQ 110 TFSVLACYNG120 SPSGVYQCAM130 RPNFTIKGSF140 LNGSGSVGFN151 IDYDCVSFCY 161 MHHMELPTGV171 HAGTDLEGNF181 YGPFVDRQTA191 QAAGTDTTIT201 VNVLAWLYAA 211 VINGDRWFLN221 RFTTTLNDFN231 LVAMKYNYEP241 LTQDHVDILG251 PLSAQTGIAV 261 LDMCASLKEL271 LQNGMNGRTI281 LGSALLEDEF291 TPFDVVRQCS301 GVTFQ |
|||||
|
||||||
PDB ID: 6XB2 Room temperature X-ray crystallography reveals catalytic cysteine in the SARS-CoV-2 3CL Mpro is highly reactive: Insights for enzyme mechanism and drug design | ||||||
Method | X-ray diffraction | Resolution | 2.10 Å | Mutation | No | [1] |
PDB Sequence |
SGFRKMAFPS
10 GKVEGCMVQV20 TCGTTTLNGL30 WLDDVVYCPR40 HVICTSEDML50 NPNYEDLLIR 60 KSNHNFLVQA70 GNVQLRVIGH80 SMQNCVLKLK90 VDTANPKTPK100 YKFVRIQPGQ 110 TFSVLACYNG120 SPSGVYQCAM130 RPNFTIKGSF140 LNGSCGSVGF150 NIDYDCVSFC 160 YMHHMELPTG170 VHAGTDLEGN180 FYGPFVDRQT190 AQAAGTDTTI200 TVNVLAWLYA 210 AVINGDRWFL220 NRFTTTLNDF230 NLVAMKYNYE240 PLTQDHVDIL250 GPLSAQTGIA 260 VLDMCASLKE270 LLQNGMNGRT280 ILGSALLEDE290 FTPFDVVRQC300 SGVTFQ |
|||||
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Room-temperature X-ray crystallography reveals the oxidation and reactivity of cysteine residues in SARS-CoV-2 3CL M(pro): insights into enzyme mechanism and drug design. IUCrJ. 2020 Sep 21;7(Pt 6):1028-35. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.